• AEsheron@lemmy.world
    link
    fedilink
    English
    arrow-up
    1
    ·
    1 year ago

    In addition to that, I’ve heard that a large portion of that R&D spending is on iterating drugs they already own so that when the patent runs out they can patent a new version and lobby the old one to be made obsolete so generics can’t be made.